New York, NY, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Sarcopenia Market by Supplement Type (Protein Supplement, Vitamin D & Calcium Supplement, and Vitamin B12 Supplement) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Hypermarket & Supermarket): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2024”. According to the report, the global sarcopenia market was valued at approximately USD 2,203 million in 2017 and is expected to generate revenue of around USD 2,958 million by 2024, growing at a CAGR of around 4.3% between 2018 and 2024.
Sarcopenia is a condition associated with the aging that leads to the loss of muscle mass and strength over time. It mostly affects people over the age of 30. Sarcopenia affects the quality of life and reduces the level of physical activities, and causes a deficiency of vitamins and nutrition. This can lead to the withdrawal of important amino acids from the body, which can worsen the condition. The treatment options include intake of protein supplements to provide the required nutrition to the body and strength building exercises, such as weight lifting. It can be categorized into presarcopenia—loss of muscle mass, sarcopenia—loss of muscle, and severe sarcopenia involves loss of muscles that severely affects the normal functioning of the body.
Browse through 54 Tables & 12 Figures spread over 110 Pages and in-depth TOC on “Global Sarcopenia Market Size 2018: Industry Type, Share, Trends, Growth, Analysis and Forecast 2024”.
Request Free Sample Report of Global Sarcopenia Market Report @ https://www.zionmarketresearch.com/sample/sarcopenia-market
The major factor likely to drive the global sarcopenia market over the forecast time period is the increasing prevalence of sarcopenia. As per the International osteoporosis foundation, the global prevalence of sarcopenia among the aging population is expected to rise from 11.1% in 2016 to 12.9% by 2045 coupled with the increasing cases of obesity and aging population. The Population Reference Bureau Report in “Aging in the United States” published the number of Americans over the age of 65 or above will be more than double by 2060, i.e., from 46 million in 2016 to over 98 million by 2060. As per the World Health Organization 2016, nearly 650 million adults globally are obese. There is no permanent cure for obesity, which has led to an increase in research and development activities for the development of better treatment options. Furthermore, change in government policies pertaining to research and development activities and disease management activities are further expected to fuel this market in the near future. However, the non-availability of new drugs is expected to limit the sarcopenia market in the upcoming years.
Sarcopenia market is segmented on the basis of supplement type and distribution channel. By supplement type, this market includes protein supplement, Vitamin D and calcium supplement, and Vitamin B12 supplement. Protein supplements are expected to dominate the market over the forecast time period. By distribution channel, the sarcopenia market includes hospital pharmacies, retail pharmacies, online pharmacies, and hypermarket and supermarket. Online pharmacies are expected to experience a rapid rate of growth over the forecast time period.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/sarcopenia-market
North America is expected to dominate the sarcopenia market over the forecast period, owing to the presence of developed economies, such as the U.S. and Canada, developed healthcare facilities and infrastructure, and increased awareness among people. Moreover, high focus on healthcare, rapid technological breakthroughs, and affordability and availability of expensive tests are likely to fuel the sarcopenia market in the estimated time period.
Europe is likely to be the second largest sarcopenia market over the forecast time period and closely follow North America. Technological advancements, the increase in research and development activities, and the rise in the investments made by major market players to develop better medical treatment procedures/methods are expected to drive this regional sarcopenia market in the future.
Browse the full "Sarcopenia Market by Supplement Type (Protein Supplement, Vitamin D & Calcium Supplement, and Vitamin B12 Supplement) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Hypermarket & Supermarket): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2024" Report At https://www.zionmarketresearch.com/report/sarcopenia-market
The Asia Pacific is likely to be the fastest growing region over the forecast time period, due to the presence of developing economies, such as India and China. A large population base in these developing economies, the increase in research activities, and the rise in the awareness among people are major factors anticipated to promote the development of this regional sarcopenia market over the forecast time period.
Latin American and the Middle Eastern and African markets are expected to expand considerably, owing to the lack of awareness among people about sarcopenia. Increasing cases of malnutrition results in poor nutritional status and deficiency of vitamins and proteins, which is further anticipated to augment the sarcopenia market over the forecast time period.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/sarcopenia-market
Some of the major players operating in the global sarcopenia market include Abbott Laboratories, Pfizer Inc., Eli Lilly and Company, Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Novartis, Cadila Healthcare, and Amway, among others.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/3631
This report segments the global sarcopenia market as follows:
Global Sarcopenia Market: Supplement Type Segment Analysis
- Protein Supplement
- Vitamin D & Calcium Supplement
- Vitamin B12 Supplement
Global Sarcopenia Market: Distribution Channel Segment Analysis
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Hypermarket & Supermarket
Global Sarcopenia Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Viral Clearance Market: https://www.zionmarketresearch.com/report/viral-clearance-market
- Ultrasound Probe Disinfection Market: https://www.zionmarketresearch.com/report/ultrasound-probe-disinfection-market
- Surgical Robots Market: https://www.zionmarketresearch.com/report/surgical-robots-market
- Neuroprosthetics Market: https://www.zionmarketresearch.com/report/neuroprosthetics-market
- Molecular Breeding Market: https://www.zionmarketresearch.com/report/molecular-breeding-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://usindustrynews.com | http://europeindustrynews.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com